Skip to main content

CapForce Inc.

CFOR
Exchange
OTC
Industry
Services-Medical Laboratories
SEC CIK
0001293818

No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding CapForce Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CFOR: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders28125−2
Shares4.12M46.0K3.45M−616.9K (−15.2%)
Value$3.08M$35.0K$1.88M−$1.17M (−38.3%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held CapForce Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CFOR in Q2 2022
InstitutionSharesValue% of portfolio
Two Sigma Securities, LLC120,964$66.0K0.01%
Great Valley Advisor Group, Inc.25,100$14.0K0.00%
Citadel Advisors LLC15,019$8.00K0.00%
Huntington National Bank42$00.00%

Sold out (6)

Institutions that held CapForce Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CFOR in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Gsa Capital Partners LLP97,810$73.0K
Virtu Financial LLC68,908$52.0K
Jane Street Group, LLC29,066$22.0K
First Republic Investment Management, Inc.17,000$13.0K
HRT Financial LP15,760$11.0K
Morgan Stanley1,370$1.00K

Not filed for Q2 2022 yet (1)

Institutions that held CapForce Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CFOR in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Susquehanna Fundamental Investments, LLC46,000$35.0K